Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 52

Results For "NTU"

1064 News Found

Combination of ‘Siddha’ drugs reduces anemia in adolescent girls: Study
News | September 10, 2024

Combination of ‘Siddha’ drugs reduces anemia in adolescent girls: Study

The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme


Beiersdorf and Macro Biologics announce partnership to develop antimicrobial peptides
News | September 06, 2024

Beiersdorf and Macro Biologics announce partnership to develop antimicrobial peptides

Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare


Amcor appoints Peter Konieczny as CEO
People | September 06, 2024

Amcor appoints Peter Konieczny as CEO

Konieczny has served as Interim CEO since April 2024


Vaishali Pharma Ltd recommends 1:1 bonus issue and 1:5 stock split
News | August 30, 2024

Vaishali Pharma Ltd recommends 1:1 bonus issue and 1:5 stock split

The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector


Mangalam Drugs & Organics awarded US$ 274,800 grant by MMV
News | August 27, 2024

Mangalam Drugs & Organics awarded US$ 274,800 grant by MMV

The grant is designated for the research and development of Pyronaridine


Zydus to acquire 50% stake in Sterling Biotech from Perfect Day
News | August 24, 2024

Zydus to acquire 50% stake in Sterling Biotech from Perfect Day

The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets


Lupin receives Health Canada approval for biosimilar Pegfilgrastim
News | August 23, 2024

Lupin receives Health Canada approval for biosimilar Pegfilgrastim

Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim


Mangalam Drugs & Organics expanding anti-malaria APl portfolio with introduction of Pyronaridine
Drug Approval | August 21, 2024

Mangalam Drugs & Organics expanding anti-malaria APl portfolio with introduction of Pyronaridine

This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability


Aptar’s nasal unidose system delivers FDA-approved neffy
News | August 19, 2024

Aptar’s nasal unidose system delivers FDA-approved neffy

This marks the first regulatory approval worldwide for nasally-delivered epinephrine